Keyphrases
CYP2C70
62%
Bile Acids
60%
Bile Acid Composition
42%
Human-like
42%
Liver Pathology
40%
Hydrophobicity
24%
Microbiota Depletion
20%
Colesevelam
20%
Inflammatory Liver Disease
20%
Gut Microbiota
20%
KO Mice
20%
Acid Activation
20%
Sequestration
20%
WT Mice
9%
Antibiotics
8%
Signaling Pathway
7%
Muricholic Acid
6%
Bile Acid Pool
5%
Human Liver Diseases
5%
Cholestatic Liver Disease
5%
Metabolic Liver Disease
5%
Urinary Podocyte
5%
Senolytic Therapy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Acid
100%
Mouse
65%
Farnesoid X Receptor
30%
Hydrophobicity
24%
Knockout Mouse
22%
Colesevelam
20%
Hepatitis
20%
Intestine Flora
20%
Antibiotic Agent
12%
Wild Type Mouse
11%
Mouse Model
9%
Chenodeoxycholic Acid
8%
Liver Disease
8%
Receptor
7%
Cytochrome P450 Family 2
7%
Polypeptide
7%
Microbiome
5%
Medicine and Dentistry
Bile Acid
80%
Liver Pathology
40%
Colesevelam
20%
Gut Microbiota
20%
Adipose Tissue
20%
Farnesoid X Receptor
20%
Hepatitis
20%
Antibiotics
11%
Chenodeoxycholic Acid
10%
Cytochrome P450 Family 2
10%
Diabetes
10%
Polypeptide
10%
Bile Acid Metabolism
8%
Insulin Sensitivity
8%
Signal Transduction
5%
Liver Disease
5%
Water-Electrolyte Imbalance
5%
Macrophage
5%
Monocyte
5%
Inflammatory Mediator
5%
Diastolic Function
5%
Cellular Senescence
5%
Adipogenesis
5%
Promoter Region
5%
Insulin Resistance
5%
P16
5%
Podocyte
5%
Microalbuminuria
5%
Glucose Tolerance
5%